Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with iliofermoral thrombosis without rekanalisation | subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did not undergo recanalisation |
| |
| Patients with ilifermoral thrombosis with rekanalisation | subjects with proven iliofemoral thrombosis (V. cava-aplasia, pelvic vein thrombosis, VTE) which was proven by objective methods such as Duplex sonography, CT/MRT, phlebography and who did undergo recanalisation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| thrombophilia screening | Genetic | genetic Evaluation of Factor-V-Leiden, Factor-II_G20210A Mutation; |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence and severity of postthrombotic Syndrome after iliofemoral thrombosis | The incidence and severity of postthrombotic Syndrome will be measured by te VILALLTA-Score | up to 20 years after occurrence of iliofemoral thrombosis |
| Measure | Description | Time Frame |
|---|---|---|
| Distribution of gender in Iliofemoral thrombosis | Distribution of gender (man or woman) | since 1996 |
| Distribution of affected side in Iliofemoral thrombosis | distribution of affected side (left or right side) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Subjects with previous iliofermoral thrombosis, which has been proven by objective measurements (Duplex sonography, phlebography, CT/MRT)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Edelgard Lindhoff-Last, Prof. | Cardioangiologisches Centrum Bethanien | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cardioangiologisches Centrum Bethanien | Frankfurt am Main | Hesse | 60389 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054070 | Postthrombotic Syndrome |
| ID | Term |
|---|---|
| D020246 | Venous Thrombosis |
| D013927 | Thrombosis |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
whole blodd, serum
| since 1996 |
| Disease-specific quality of life instrument for use in venous diseases of the leg (VEINES-QOL) | A quality of life questionaire comprises 25 items that quantify disease effect on quality of life | 1 year |
| Incidence of venous claudication | Walking distance on treadmill | 1 year |
| D002318 |
| Cardiovascular Diseases |
| D014689 | Venous Insufficiency |